MEDNAX, INC. (NYSE:MD) Files An 8-K Submission of Matters to a Vote of Security Holders

MEDNAX, INC. (NYSE:MD) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07

Submission of Matters to a Vote of Security Holders.

On May16, 2018, MEDNAX, Inc., a Florida corporation (the “Company”), held its 2018 Annual Shareholders’ Meeting (the “Annual Meeting”). Of the 94,382,958 shares of common stock outstanding and entitled to vote,80,104,963 shares were represented, constituting a quorum.The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting are as follows:

Proposal 1: All of the Board’s nominees for Director were elected to serve until the Company’s 2019 Annual Shareholders’ Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below:

Name	For	Withheld	Broker Non-Vote
Cesar L. Alvarez	60,414,183	14,875,864	4,814,916
Karey D. Barker	65,474,986	9,815,061	4,814,916
Waldemar A. Carlo, M.D.	57,711,214	17,578,833	4,814,916
Michael B. Fernandez	58,687,051	16,602,996	4,814,916
Paul G. Gabos	63,762,666	11,527,381	4,814,916
Pascal J. Goldschmidt, M.D.	64,145,112	11,144,935	4,814,916
Manuel Kadre	61,273,031	14,017,016	4,814,916
Roger J. Medel, M.D.	64,230,027	11,060,020	4,814,916
Enrique J. Sosa, Ph.D.	63,042,327	12,247,720	4,814,916

Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2018 fiscal year was ratified by the shareholders, by the votes set forth in the table below:

For	Against	Abstained	Broker Non-Vote
77,993,626	2,095,031	16,306

Proposal 3: The shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, by the votes set forth in the table below:

For	Against	Abstained	Broker Non-Vote
55,498,607	19,671,689	119,751	4,814,916

About MEDNAX, INC. (NYSE:MD)
MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.